Literature DB >> 15063344

Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography.

Vivien Chan1, Bruce G Charles, Susan E Tett.   

Abstract

A simple method for the measurement of the active leflunomide metabolite A77 1726 in human plasma by HPLC is presented. The sample workup was simple, using acetonitrile for protein precipitation. Chromatographic separation of A77 1726 and the internal standard, alpha-phenylcinnamic acid, was achieved using a C(18) column with UV detection at 305 nm. The assay displayed reproducible linearity for A77 1726 with determination coefficients (r2) > 0.997 over the concentration range 0.5-60.0 microg/ml. The reproducibility (%CV) for intra- and inter-day assays of spiked controls was <5%. The limit of quantification was 0.8 microg/ml. The average absolute recovery was approximately 100%. This assay is suitable for the determination of A77 1726 in plasma of patients taking leflunomide, and is simpler to use than other HPLC methods reported previously.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063344     DOI: 10.1016/j.jchromb.2004.01.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis.

Authors:  Vivien Chan; Bruce G Charles; Susan E Tett
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

2.  Rapid Stability Indicating HPLC Method for the Analysis of Leflunomide and Its Related Impurities in Bulk Drug and Formulations.

Authors:  Useni Reddy Mallu; Venkateswara Rao Anna; Bikshal Babu Kasimala
Journal:  Turk J Pharm Sci       Date:  2019-11-11

Review 3.  Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature.

Authors:  Joan C Y Ng; Marianna Leung; Alissa J Wright; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 5.577

4.  Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.

Authors:  Todd M Archer; Charlee Mulligan; Lakshmi Narayanan; Caitlin Riggs; Claire Fellman; John M Thomason; Robert W Wills; Dawn M Boothe; Crisanta Cruz-Espindola; Roy Harmon; Andrew J Mackin
Journal:  J Vet Intern Med       Date:  2020-02-13       Impact factor: 3.333

5.  Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide-Development and Validation of the Novel Analytical Method.

Authors:  Bartłomiej Sankowski; Sylwia Michorowska; Emilia Raćkowska; Mariusz Sikora; Joanna Giebułtowicz
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.